Lenalidomide(Revlimid)

Release date: 2026-01-05 14:20:33     Recommended: 30

It is used for the treatment of various hematological diseases such as multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma.